EID Parry India Limited (EIDPARRY)
Large CapFMCG stocks · Large cap · NSE
EID Parry is a diversified Indian company with interests in Sugar & Biofuels, Nutraceuticals, and Consumer Products. It operates sugar plants and distilleries across South Indian states, focusing on operational efficiency and portfolio reshaping for long-term value creation.
One read, four checks
75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.
Weak fundamentals, management trust is acceptable, price trend argues for patience, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
low confidence · 0/0 claims checked
Timing lens: price trend and sector relative strength.
Rolling lens: recent quarterly delivery, not the latest single-result score.
Quarter ended 30 Jun 2026
Bad · 0/100PAT -33% YoY · margin compression · Rev +3% YoY · +14% QoQ
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹9,018 Cr | +3.4% | +14.4% |
| EBITDA | ₹751 Cr | -6.7% | +22.9% |
| Operating margin | 8.0% | -100 bps | +0 bps |
| PAT | ₹312 Cr | -32.8% | NDF |
| PAT margin | 3.5% | -186 bps | +710 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Business & thesis
Growth engines, tailwinds/headwinds, and risk radar from management commentary
Business & thesis
Growth engines, tailwinds/headwinds, and risk radar from management commentary
Where growth can come from, and what can break the case
FY26 results show a challenging year with consolidated revenue from operations at INR 7,055 Cr (down 6.2% YoY) and a PBT loss of INR 216 Cr (vs loss of INR 74 Cr YoY), impacted by significant exceptional items and underperforming segments.
Management acknowledges a challenging year, undertaking portfolio reshaping and exiting a business. Consolidated losses increased significantly due to exceptional items and underperforming segments like Consumer Products and Distillery. A strategic reset is underway, but execution and turnaround in loss-making segments are critical.
Consumer Products Portfolio Premiumization
Transition to value-added, brand-led portfolio (jaggery & other sweeteners) and de-focus from lower-contribution bulk categories like rice and pulses.
Nutraceuticals Market Expansion & New Products
Regaining share in key EU and US markets, expanding in emerging markets, and progressing entry into new product segments around Derma/Hair Health.
Sugar & Biofuels Revenue Maximization
Maximising revenue streams across sugar, co-generation, and distillery segments through operational efficiencies and cost reduction.
New Jaggery Facility
Investment in a new state-of-the-art Jaggery facility in Karnataka is underway, expected to be commissioned by the end of FY27 Q3.
Domestic Sugar Pricing Outlook
Projected lower cane output and closing stock in SY26E are expected to lead to a Neutral/Positive pricing outlook.
Branded Sugar Market Growth
Branded white sugar market in India expected to grow at ~8-9% p.a. to ~INR 8,000 Cr by 2030, driven by increased branded penetration.
Niche Sweeteners Adoption
Non-sugar/Jaggery-based sweeteners constitute ~2% of the market but are driving growth at ~30%.
Sugar & Biofuels Cost Pressures
Increasing cost pressures, unfavorable economics in the Ethanol segment, and a dull market for Sugar exports.
Distillery Segment Profitability
Loss due to increase in feed stock cost and reduction in selling price.
Consumer Products Performance
Increase in loss due to lower sales volume, higher input costs, and channel corrections.
Geopolitical and Policy Uncertainty
Management highlights the need to navigate an uncertain geopolitical and policy environment.
Portfolio Realignment Challenges
Decision to exit Parry Sugars & Refinery business due to operational challenges, structural unviability, and high debt.
Underperforming Bulk Categories
Initial foray into lower-contribution bulk categories such as rice and pulses did not meet expectations.
Management accountability
What management said, and what results must prove
Management accountability
What management said, and what results must prove
What management said, and what results must prove
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is essential for understanding full-year performance and the impact of seasonality in the sugar business. QoQ provides insight into recent momentum and the immediate effects of strategic resets in Consumer Products and Nutraceuticals.
Sugar Revenue (FY26)
INR 5,366 Cr (vs INR 5,781 Cr FY25)
Sugar PBT (FY26)
INR 54 Cr (vs loss of INR 115 Cr FY25)
Distillery PBT (FY26)
Loss of INR 14 Cr (vs profit of INR 37 Cr FY25)
Nutraceuticals PBT (FY26)
INR 19 Cr (vs INR 3 Cr FY25)
FY27 Priorities: 'Disciplined Renewal'
Focus on strengthening the core, driving margin improvement, stronger working capital/cash flow management, and accelerating digital/AI-led transformation.
Consumer Products Strategic Reset
FY25-26 marked a year of strategic reset and sharper prioritization, recalibrating away from lower-contribution bulk categories towards value-added segments.
Numbers and claims to verify in the next filings
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Sugar Segment PBT | INR 54 Cr (FY26) | Sustained profitability improvement and positive impact from operational efficiencies. |
| Distillery Segment PBT | Loss of INR 14 Cr (FY26) | Reversal of losses, indicating better management of feedstock costs and selling prices. |
| Consumer Products PBT | Loss of INR 109 Cr (FY26) | Margin expansion and improved profitability from portfolio premiumization and channel strategies. |
| New Jaggery Facility Commissioning | Expected by end of FY27 Q3 | Timely completion and successful ramp-up of the new facility in Karnataka. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trend score and candlestick chart
44NeutralSMA20 +2.1% / mo · MACD −
Technical chart
EIDPARRYdaily · 1Y · AUTO-6.3%Daily technical trend read
Bearish setupTrend is weak — long-term trend down. RSI 47.
- Price below SMA200 (long-term downtrend) — short-term bounces likely countertrend.
- SMA20 rising (~2.0% over last month) — short-term momentum positive.
- RSI(14) at 47 — falling, no extreme reading.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- 30% off 52W high · 12% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Relative Strength & Trend Stage
- Price is 2.3% below the 30-week proxy.
- The 50-DMA is below the 30-week proxy and its slope is falling -1.9%.
Valuation & score drivers
U-Score 33 · WATCHLIST · pillar breakdown, sector model, fair-value anchor
Valuation & score drivers
U-Score 33 · WATCHLIST · pillar breakdown, sector model, fair-value anchor
Fundamental score breakdown
WATCHLISTWhy this score?
Top U-Score contributors and drags from the latest stored fundamentals.
Positive drivers
- Piotroski is strong at 8/9.
- Balance sheet contributes 8/15 to the score.
- Cash flow contributes 4/10 to the score.
Main drags
- Fair-value margin of safety is negative at -82.3%.
- Quality is weaker at 1/20; verify the latest quarterly trend.
- Valuation is weaker at 7/30; verify the latest quarterly trend.
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Score history
12 stored score snapshots. Latest stored move: +1 points.
Factor attribution
Modelled fair value
Trust score
Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth
Trust score
Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Mixed Trust: Claim history is still being built. It ranks around the 56th percentile of the scored universe and 14th percentile within FMCG. Main check: financial discipline is weak at 52/100.
Healthy Trust Lite: Promoter pledge is zero. Key concern: 2 latest quarters had PAT decline worse than 25% YoY.
Usable, but needs evidence. Treat guidance with a margin of safety.
overall median 67 · FMCG: 14th pctile, median 78 · Large: 32nd pctile, median 73
66 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Mixed Trust · low confidenceRead Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust positives
- ▸Promoter pledge is zero.
- ▸4 years of positive FCF.
- ▸4/4 latest quarters had positive YoY revenue growth.
- ▸OPM spread across recent quarters is 2%.
Trust risks
- ▸2 latest quarters had PAT decline worse than 25% YoY.
- ▸ROE is low at 7.9%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Financials
Full fundamentals table and 10-year revenue / profit / ROE history
Financials
Full fundamentals table and 10-year revenue / profit / ROE history
Fundamentals
Valuation
- P/E
- 17.10
- P/B
- 1.58
- EV/EBITDA
- 4.13
- Market Cap
- 13905.00Cr
Profitability
- ROE
- 7.85%
- ROCE
- 17.00%
- ROA
- 4.20%
- Dividend Y
- —
Growth (CAGR)
- Revenue 5Y
- 16.00%
- EPS 5Y
- 7.00%
- Revenue 3Y
- 3.00%
- EPS 3Y
- -11.00%
Balance Sheet
- Debt/Equity
- 0.40
- Interest Coverage
- 7.30×
- Altman Z
- 2.65
- Book Value
- 493.00
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 4/5
- OCF
- 1542.00 Cr
- EPS TTM
- 26.13
Shareholding
- Promoter Hold
- 41.28%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 19%
Financial History
Updated 5/9/2026
Revenue
₹ CrNet Profit
₹ CrReturn on Equity
%Peers
Business-comparable names in FMCG, ranked by similarity
Peers
Business-comparable names in FMCG, ranked by similarity
Peers
Business-comparable peers in FMCG — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.